
Clay McLeod is manager of bioinformatics software development in the Computational Biology Department.
Clay McLeod came to St. Jude looking for a challenge.
He sought a role where he could be innovative, make significant contributions and grow his career. Since joining St. Jude in June 2016, he’s done that and more—creating next-generation sequencing pipelines and helping launch the revolutionary data-sharing tool St. Jude Cloud.
“I’ve always enjoyed working on things that have the potential to make a significant impact. In my job interview, I expressed that I wanted to work on the front lines and be on the cutting edge,” McLeod said.
As a senior software engineer in Computational Biology, McLeod was hired to write or build pipelines to analyze the clinical genomics data of eligible St. Jude cancer patients. St. Jude performs whole-genome, whole-exome and RNA sequencing to assess patients’ complete molecular profiles.
After working for more than a year on the clinical genomics project, McLeod moved into a lead engineering role building St. Jude Cloud. A partnership with Microsoft and DNAnexus, St. Jude Cloud is the world’s largest public repository of pediatric cancer genomics data. Researchers worldwide can access genomic data, genomic analysis tools and interactive visualizations.
McLeod served as the primary project manager from the St. Jude side, coordinating a wide range of tasks from software development to outreach strategy to video production. He worked with a multidisciplinary team to guide the project to a successful launch in April 2018, while coordinating a major transition in the internal cloud-based analysis platform.
St. Jude has deposited more than 5,000 whole-genome, 5,000 whole-exome and 1,200 RNA-Seq samples from more than 5,000 pediatric cancer patients and survivors. The goal is to host 10,000 whole genomes by the beginning of 2019.
Seeing the Cloud project from concept through development and into implementation has been most rewarding for McLeod.
“Being on the forefront of this technology and helping to move the world forward is both rewarding and challenging,” McLeod said.
McLeod, a native Memphian, had offers from organizations across the country, but he wanted to stay in his hometown to make the biggest impact. St. Jude provides him the challenges and vision that help him do his best work.
“I’m a huge advocate for the city of Memphis, and I love working at St. Jude,” McLeod said.
Earlier this year, McLeod was promoted to manager of bioinformatics software development. In October, he received the 2018 Amos Jacobs award—the hospital’s top employee honor.
“My work gets me excited every day when I wake up,” he said. “This was exactly what I was looking for—a chance to come in and help shape the future of how St. Jude shares its data with the world.”
Read more inspiring stories
-
Why did I get the COVID-19 vaccine? Two St. Jude families share their stories
Two St. Jude families share their reasons for getting the COVID-19 vaccine.
-
Puggle, Huckleberry to depart soon; doggy duo has changed the patient experience
The facility dogs who laid the groundwork for the hospital’s facility dog program are departing soon. Read how they changed the patient experience.
-
Face masks are business as usual at St. Jude
Learn how staff members, patients and families have been wearing masks correctly for decades to protect children and prevent infection.
-
Meet Rosalie: Facility dog to provide employee support
Learn how Rosalie, a golden retriever facility dog, will help support employee resilience. St. Jude has two other facility dogs who support patient care.
-
St. Jude Paws at Play to expand by four paws
Learn how the hospital’s Resilience Center is expanding to welcome a new facility dog dedicated to employees.
-
COVID-19 vaccines not linked to infertility
Virtually all research outcomes have discredited infertility concerns regarding the COVID-19 vaccines. Learn more.
-
The science behind COVID-19 vaccines
It may seem like the COVID-19 vaccine moved quickly to emergency use authorization and approval, but in reality, researchers used years of data, research and advances to fast-track the lifesaving vaccines. Read about it.
-
How does employee vaccination help protect St. Jude patients?
St. Jude patients are among the most vulnerable when it comes to COVID-19. We must do all we can to protect them—and that means that every single employee must be vaccinated. Diego Hijano, MD, explains why in this Q&A.
-
Whether you've had the virus or not, COVID-19 vaccination boosts your immune response and offers the best line of protection
A positive test does not equal protection against COVID-19. Getting vaccinated after COVID-19 will boost your immune response and protect you against new variants of the virus. Learn more
-
COVID-19 vaccine side effects: How common are they?
Find out how you can wade through the deluge of information about vaccine side effects and make an informed choice.
-
Human Resources’ Kynis Douglas honors her father’s memory by getting vaccinated
Kynis Douglas, Human Resources, got the COVID-19 vaccine to honor her father’s memory after he died from the disease earlier this year. Learn more.
-
Kids Often Move Too Fast; COVID-19 Vaccine Production Didn’t
Learn why COVID-19 vaccines are safe and effective. It's thanks to great science, incredible collaboration and careful approval processes.
-
COVID-19 vaccines safe for those worried about fertility, pregnancy and breastfeeding
COVID-19 vaccines are safe for those worried about fertility, pregnancy and breastfeeding. Find out more.
-
High schoolers graduate in a virtual ceremony
Learn how the St. Jude School Program arranged a virtual graduation for high school students this year.
-
A virtual celebration: Kindergarteners graduate after a year of big changes
After the pandemic cancelled last year’s event, see how the St. Jude School Program coordinated a virtual kindergarten graduation this year.
Careers
At St. Jude, your career makes a difference. We offer outstanding opportunities in the basic and translational sciences, clinical research, patient care and many other areas for talented individuals.